Back to Top
Go Back
Journal Photo for Cancer Investigation
Peer reviewed only Open Access

Cancer Investigation (JSN)

Publisher : Taylor & Francis
Cancer Investigation Clinical studies precision oncology
Claim Your Journal Get PRC Visit Website
e-ISSN 1532-4192
p-ISSN 0735-7907
Issue Frequency 10-issues-year
Impact Factor 1.8
Est. Year 2025
Mobile 4402080520500
DOI YES
Language English
APC YES
Impact Factor Assignee google scholar
Email enquiries@taylorandfrancis.com

Journal Descriptions

Cancer Investigation is a well-established, international journal publishing research on all aspects of oncology. Disseminating research for more than four decades, the journal aims to provide researchers and clinicians with a comprehensive resource on the current state of progress in the field of oncology, as well as a broad background of reliable information necessary for effective decision-making. Cancer Investigation provides a unique, nimble, cutting-edge publishing platform for a broad range of topics spanning the spectrum of oncology and the rapidly changing landscape of oncology.

Cancer Investigation (JSN) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Cancer Investigation, Clinical studies, precision oncology, genomic medicine, novel technologies, Art of Medicine, letters to the editor , Online or Print , 10-issues-year Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0735-7907, E-ISSN: 1532-4192, Established: 2025, Impact Factor: 1.8
  • Provides Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of JSN

ACB-PCR Quantification of K-RASCodon 12 GAT and GTT Mutant Fraction in Colon Tumor and Non-Tumor Tissue
Barbara L April, 2010
K-RAS mutation is being developed as a cancer biomarker and tumor K-RAS is being used to predict therapeutic response. Yet, levels of K-RAS mutation in normal and pathological tissue samples...
EGFRGene Overexpression Retained in an Invasive Xenograft Model by Solid Orthotopic Transplantation of Human Glioblastoma Multiforme Into Nude Mice
Zhenqiang Huang February, 2011
Orthotopic xenograft animal model from human glioblastoma multiforme (GBM) cell lines often do not recapitulate an extremely important aspect of invasive growth and epidermal growth factor r...
Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Susanna V. April, 2011
Most patients with non-small cell lung cancer (NSCLC) present with advanced disease requiring systemic chemotherapy. Treatment with the antiangiogenic agent bevacizumab in combination with s...
Infused Therapy and Survival in Older Patients Diagnosed with Metastatic Breast Cancer who Received Trastuzumab
Robert I. September, 2011
We used Surveillance, Epidemiology, and End Results–Medicare data (2000–2006) to describe treatment and survival in women diagnosed with metastatic breast cancer (MBC) who received trast...
Patterns of Response in Patients with Pretreated Metastatic Melanoma who Received Ipilimumab 3 mg/kg in a European Expanded Access Program: Five Illus...
Bart Neyns October, 2012
Ipilimumab 3 mg/kg was the first agent to improve survival of pretreated advanced melanoma patients. Nonconventional response patterns to ipilimumab have been reported widely, but most of th...
A Walnut-Enriched Diet Reduces the Growth of LNCaP Human Prostate Cancer Xenografts in Nude Mice
Russel J. June, 2013
It was investigated whether a standard mouse diet (AIN-76A) supplemented with walnuts reduced the establishment and growth of LNCaP human prostate cancer cells in nude (nu/nu) mice. The waln...
Stromal–Epithelial Crosstalk Provides a Suitable Microenvironment for the Progression of Ovarian Cancer Cellsin Vitro
Wei Sun October, 2013
The tumor microenvironment plays an important role in the progression of cancer. This study focused on carcinoma-associated fibroblasts (CAFs) and stromal–epithelial interaction between CA...
Clinical Significance of Atypical Glandular Cells in the Bethesda System 2001: A Comparison with the Histopathological Diagnosis of Surgically Resecte...
Tadahiro Shoji February, 2014
Forty-one patients diagnosed with atypical glangular cells (AGC) underwent surgery, and the histopathological diagnosis results for the resected specimens and the clinical features were anal...
Clinical Validation of Local Versus Commercial Genomic Testing in Cancer: A Comparison of Tissue and Plasma Concordance
Lucy G. February, 2025
Genomic sequencing of tumours improves patient outcomes through implementation of precision oncology. At present, genomic testing is mainly confined to research settings, with samples sent t...
Undervalued Criteria in the Evaluation of Multimodal Trials for Upper GI Cancers
Björn LDM September, 2014
Global economies and their health systems face a huge challenge from cancer: 1 in 3 women and 1 in 2 men will develop cancer in their lifetime. In the less developed countries, the volume of...